par Moreau, Michel
;Klastersky, Jean
;Schwarzbold, A;Muanza, Frédérique;Georgala, Aspasia
;Aoun, Michel
;Loizidou, A;Barette, Martine;Costantini, Sabrina;Delmelle, Michel;Dubreucq, L;Vekemans, Marc
;Ferrant, Augustin;Bron, Dominique
;Paesmans, Marianne 
Référence Annals of oncology, 20, 3, page (513-519)
Publication Publié, 2009-03







Référence Annals of oncology, 20, 3, page (513-519)
Publication Publié, 2009-03
Article révisé par les pairs
Titre: |
|
Auteur: | Moreau, Michel; Klastersky, Jean; Schwarzbold, A; Muanza, Frédérique; Georgala, Aspasia; Aoun, Michel; Loizidou, A; Barette, Martine; Costantini, Sabrina; Delmelle, Michel; Dubreucq, L; Vekemans, Marc; Ferrant, Augustin; Bron, Dominique; Paesmans, Marianne |
Informations sur la publication: | Annals of oncology, 20, 3, page (513-519) |
Statut de publication: | Publié, 2009-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Chemotherapy |
Febrile neutropenia | |
Hematological malignancies | |
Myelotoxicity score | |
Prediction | |
Risk model | |
MeSH keywords: | Antineoplastic Agents -- adverse effects |
Antineoplastic Agents -- therapeutic use | |
Fever -- chemically induced | |
Fever -- complications | |
Hematologic Neoplasms -- drug therapy | |
Humans | |
Neutropenia -- chemically induced | |
Neutropenia -- complications | |
Prospective Studies | |
Sensitivity and Specificity | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdn655 | |
info:pii/mdn655 | |
info:scp/61649126029 | |
info:pmid/19139177 |